Search results
Author(s):
Payam Pournazari
,
Su Min Chang
,
Stephen H Little
,
et al
Added:
1 year ago
BAV: SAVR versus TAVR
Author(s):
Arthur J Lee
,
Imran Baig
,
Katherine B Harrington
,
et al
Added:
1 year ago
Article
Author(s):
Harold Djodjo Kano
,
Wei Sun
Added:
5 months ago
Author(s):
Nils Perrin
,
Anita W Asgar
Added:
2 years ago
Author(s):
Quynh Nguyen
,
Jessica GY Luc
,
Thomas E MacGillivray
,
et al
Added:
1 year ago
Author(s):
Lauren V Huckaby
,
Bradley G Leshnower
Added:
6 months ago
Author(s):
Augusto D Pichard
Added:
5 years ago
Prof Augusto Pichard (MedStar Washington Hospital Center, Washington DC, US) discusses the Portico self-expanding aortic valve - latest iterations and status of trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology.
Questions:
1. Could you give us a brief narrative of data published on the Portico valve to date?
2. Which patients do you use the Portico Valve in?
3. For implantors, not…
View more
Author(s):
Somsupha Kanjanauthai
,
Kabir Bhasin
,
Luigi Pirelli
,
et al
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has been established as a therapeutic option for patients with severe symptomatic aortic stenosis who are considered to be of intermediate, high or prohibitive surgical risk.1–5 As a result of favorable TAVR outcomes and substantial improvements in transcatheter heart valve (THV) technologies and implantation techniques, the feasibility of broadening…
View more
Author(s):
Zvonimir Krajcer
Added:
3 years ago
Annually, in the US approximately 15,000 deaths are caused by a rupture of an abdominal aortic aneurysm (AAA), making it the 13th leading cause of death. AAA is often referred to as ‘the silent killer’ and is estimated to affect 2.7 million Americans, half of whom are not correctly diagnosed.1 If left untreated, the risk of rupture is 80–90% through progressive thinning of the aortic vessel,…
View more
Author(s):
Eden C Payabyab
,
Lindsay S Elbaum
,
Navneet Sharma
,
et al
Added:
2 years ago